BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20076888)

  • 1. [Anticardiolipin antibodies in leg ulcers].
    Skare TL; Ribas CA; Malafaia O; Ribas Filho JM; Nassif PA; Nascimento MM; Fonseca VR
    Rev Col Bras Cir; 2009 Apr; 36(2):152-6. PubMed ID: 20076888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet count and clinical profile of anticardiolipin positive leg ulcers].
    Skare TL; Ribas CA; Malafaia O; Ribas Filho JM; Nassif PA; Nascimento MM; Pachnicki JP
    Rev Col Bras Cir; 2009 Oct; 36(5):420-4. PubMed ID: 20069154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leg ulcers and anticardiolipin antibodies.
    Skare TL
    An Bras Dermatol; 2011; 86(3):596-7. PubMed ID: 21738987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activated protein C resistance and cardiolipin antibodies in leg ulcers].
    Maréchal V; De Maistre E; Barbaud A; Albuisson E; Lecompte T; Gobert B; Bene M; Faure G; Schmutz J
    Ann Dermatol Venereol; 2000; 127(6-7):585-9. PubMed ID: 10930855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leg ulcers and antiphospholipid antibodies. Prospective study of 48 cases].
    Alcaraz I; Lefevre I; Wiart T; Lafon C; Forzy G; Modiano P
    Ann Dermatol Venereol; 1999 Apr; 126(4):313-6. PubMed ID: 10421932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study.
    Runchey SS; Folsom AR; Tsai MY; Cushman M; McGovern PD
    Br J Haematol; 2002 Dec; 119(4):1005-10. PubMed ID: 12472581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP
    Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies: a study in cerebral venous thrombosis.
    Christopher R; Nagaraja D; Dixit NS; Narayanan CP
    Acta Neurol Scand; 1999 Feb; 99(2):121-4. PubMed ID: 10071172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease.
    Puisieux F; de Groote P; Masy E; Di Pompeo C; Millaire A; Bouillanne O; Jude B; Dewailly P; Ducloux G
    Am J Med; 2000 Dec; 109(8):635-41. PubMed ID: 11099683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies and ulcerations of the leg.
    Barbaud AM; Gobert B; Reichert S; Schmutz JL; Bene MC; Weber M; Faure GC
    J Am Acad Dermatol; 1994 Oct; 31(4):670-1. PubMed ID: 8089297
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.
    Gómez-Pacheco L; Villa AR; Drenkard C; Cabiedes J; Cabral AR; Alarcón-Segovia D
    Am J Med; 1999 Apr; 106(4):417-23. PubMed ID: 10225244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticardiolipin antibodies and lower leg plaques and ulcers of 45 years duration.
    Bissonnette R; Tousignant J
    Int J Dermatol; 1993 Aug; 32(8):619. PubMed ID: 8407085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticardiolipin antibodies in patients with systemic lupus erythematosus].
    Petrović R; Petrović M; Novicić-Sasić D; Damjanov N
    Srp Arh Celok Lek; 1994; 122 Suppl 1():98-100. PubMed ID: 18173204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular dementia and anticardiolipin antibodies.
    de Godoy JM; de Godoy MR; Cipulo JP; Tognola VA
    Med Sci Monit; 2005 Sep; 11(9):CR430-3. PubMed ID: 16127362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of serum anticardiolipin antibody levels in coronary heart disease.
    Yilmaz E; Adalet K; Yilmaz G; Badur S; Erzengin F; Koylan N; Ozsaruhan O; Ertem G; Büyüköztürk K
    Clin Cardiol; 1994 Mar; 17(3):117-21. PubMed ID: 8168279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticardiolipin antibodies in leprosy.
    Thawani G; Bhatia VN; Mukherjee A
    Indian J Lepr; 1994; 66(3):307-14. PubMed ID: 7861045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients.
    Phillips AO; Jones HW; Hambley H; Hillis AN; Hendry BM
    Nephron; 1993; 65(3):350-3. PubMed ID: 8289982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus.
    Fonseca E; Alvarez R; González MR; Pascual D
    Lupus; 1992 Aug; 1(4):265-8. PubMed ID: 1301991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
    Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
    Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.